A review of vaccine clinical trials for non-small cell lung cancer.
about
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer VaccinesLung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
P2860
A review of vaccine clinical trials for non-small cell lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A review of vaccine clinical trials for non-small cell lung cancer.
@ast
A review of vaccine clinical trials for non-small cell lung cancer.
@en
type
label
A review of vaccine clinical trials for non-small cell lung cancer.
@ast
A review of vaccine clinical trials for non-small cell lung cancer.
@en
prefLabel
A review of vaccine clinical trials for non-small cell lung cancer.
@ast
A review of vaccine clinical trials for non-small cell lung cancer.
@en
P2860
P356
P1476
A review of vaccine clinical trials for non-small cell lung cancer.
@en
P2093
Nemunaitis J
P2860
P304
P356
10.1517/14712598.7.1.89
P407
P577
2007-01-01T00:00:00Z